| 原料品名 | ATORVASTATIN CALCIUM TRIHYDRATE USP |
|---|---|
| 原料中文名称 | 阿托伐他汀钙三水合物 |
| 中文别名 | 阿托伐他汀钙水合物;阿托伐他汀钙三水物;ATORVASTATIN CALCIUM 阿托伐他汀钙;阿托伐他汀钙盐三水化物;阿托伐他汀钙三水合物;阿托伐他汀钙水合物 |
| 化学名称 | calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate;trihydrate |
| 分子式 | C66H74CaF2N4O13 |
| 分子量 | 1209.38756 |
| CAS号 | 344423-98-9 |
| 结构式图片 | 暂无权限 |
| 美国DMF登记 | 暂无权限 |
供应商信息
| 企业名称 | LAURUS LABS LTD |
|---|---|
| 地址 | 21,Jn Pharma City,Parawada,Visakhapatnam 531021,Ap,India |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司简介 | We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. Continuous innovation is the lifeblood of our business. Therefore, we undertake dedicated R&D in areas that have significant growth potential. We filed 257 patents in which we own 116 patents. We have commercialised 60+ products since inception across four distinct business units: Generics API, Generics FDF, Ingredients and Synthesis. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息（https://s.yaozh.com/Purchase/release），或联系药智通客服17318480790（微信同号） |
扩展信息
